Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

X4 Pharmaceuticals (XFOR) Times Interest Earned (2018 - 2025)

X4 Pharmaceuticals (XFOR) has disclosed Times Interest Earned for 8 consecutive years, with -$12.19 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Times Interest Earned rose 14.72% year-over-year to -$12.19, compared with a TTM value of -$11.0 through Sep 2025, down 254.71%, and an annual FY2024 reading of -$4.15, up 77.69% over the prior year.
  • Times Interest Earned was -$12.19 for Q3 2025 at X4 Pharmaceuticals, down from -$11.75 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $32.68 in Q2 2024 and bottomed at -$31.41 in Q4 2021.
  • Average Times Interest Earned over 5 years is -$16.07, with a median of -$19.9 recorded in 2024.
  • The sharpest move saw Times Interest Earned surged 245.37% in 2024, then tumbled 135.97% in 2025.
  • Year by year, Times Interest Earned stood at -$31.41 in 2021, then grew by 28.82% to -$22.36 in 2022, then surged by 40.24% to -$13.36 in 2023, then decreased by 16.02% to -$15.5 in 2024, then grew by 21.37% to -$12.19 in 2025.
  • Business Quant data shows Times Interest Earned for XFOR at -$12.19 in Q3 2025, -$11.75 in Q2 2025, and -$4.29 in Q1 2025.